Kyrgyzstan Plans to Increase Minimum Prices for Tobacco Products

Sep.29.2024
Kyrgyzstan Plans to Increase Minimum Prices for Tobacco Products
Kyrgyzstan plans to increase the minimum wholesale retail prices for tobacco and nicotine products, aiming to improve public health.

According to a report by The Economist on September 27th, Kyrgyzstan plans to increase the minimum wholesale retail prices of tobacco and nicotine-containing products.


According to reports, the cabinet of Kyrgyzstan has issued a relevant resolution and is seeking public feedback. The resolution aims to increase national budget revenues and reduce citizens' consumption of harmful products to improve public health.


The resolution proposes minimum price standards for four categories of tobacco and nicotine-containing products.


Cigarettes with filtered and unfiltered tips, as well as small cigars, are available for a minimum price of 110 som (1.3 USD) for a pack of 20. Heating tobacco products, such as pods, are also priced at 110 som (1.3 USD) for a pack of 20. Disposable e-cigarettes are priced at 350 som (4 USD) each, while e-cigarettes and similar devices are priced at 1500 som (18 USD) each.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Pouchless Oral Nicotine NAKD Nicotine Pods Launch with “Garlic-Clove” Shape and Structural Design Drawing Attention
Product | Pouchless Oral Nicotine NAKD Nicotine Pods Launch with “Garlic-Clove” Shape and Structural Design Drawing Attention
NAKD nicotine pods have been launched overseas with a pouchless solid-pellet design, featuring a “garlic clove–like” appearance that is smaller than traditional nicotine pouches. Made from compostable materials and positioned around instant nicotine release, the product is developed by Norwegian brand Den Norske Snusfabrikken and is already available in several European markets.
Nov.18 by 2FIRSTS.ai
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Bloomberg reports that Japan Tobacco International (JTI) is pursuing a strategy that contrasts with peers such as Philip Morris International (PMI) and British American Tobacco (BAT). While global tobacco majors push “smoke-free” transitions, JTI continues to cultivate combustible cigarettes—particularly value brands in the United States—while advancing the global rollout of its heated-tobacco brand Ploom. JTI forecasts that value-priced cigarettes will exceed a 40% share of the U.S. market by 2
Sep.28 by 2FIRSTS.ai
SKE’s Parent Company Yinghe Technology Reports 80% Drop in Q3 Net Profit, Revenue Up 22.85% Year-on-Year
SKE’s Parent Company Yinghe Technology Reports 80% Drop in Q3 Net Profit, Revenue Up 22.85% Year-on-Year
Yinghe Technology (SZ: 300457), parent company of SKE, saw Q3 net profit plunge 80.3% to 31.06 million yuan, while revenue rose 22.85% to 2.52 billion yuan. The decline was mainly driven by higher costs and expenses.
Oct.28 by 2FIRSTS.ai
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
A bill endorsing a licensing system for tobacco and nicotine products has been recommended in Russia's State Duma.
Nov.14 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21